Download Prof. Rajiv Khanna Prof. Rajiv Khanna obtained his doctorate

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Herpes simplex research wikipedia , lookup

Transcript
Prof. Rajiv Khanna
Prof. Rajiv Khanna obtained his doctorate degree from India and
undertook his post-doctoral training at the University of Adelaide and
the Queensland Institute of Medical Research (QIMR), Brisbane
Australia. He is currently appointed as the Director of the Australian
Centre for Vaccine Development at QIMR and also holds Senior
Principal Research Fellowship from the National Health and Medical
Research Council of Australia. The major goals of his research group
are to obtain a deeper understanding of the mechanisms by which an
immune response to viruses and human cancers may be generated,
augmented and applied to control these diseases. Over the last few
years, Rajiv has successfully translated his research towards the
development of novel immune-based therapeutic strategies for the
treatment of cancer patients and transplant recipients with viral
complications. Previously, Rajiv has been appointed as a consultant to
CSL Ltd for the development of EBV vaccine. He has also acted as a
consultant to Cellestis Ltd (Australia) and Oxford Immunotech (UK) for
the development of novel diagnostic kits for predicting infectious
complications in transplant patients. Currently, he is collaborating with
an international biotech company to develop a therapeutic vaccine for
nasopharyngeal carcinoma.
Rajiv Khanna
Prof. Rajiv Khanna
Director, Australian Centre for Vaccine Development
Senior Principal Research Fellow (NH&MRC)
Queensland Institute of Medical Research
300 Herston Road, Herston (Qld) 4006 Australia